These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8429992)

  • 1. Changes in parathyroid hormone during haemodialysis sessions with two different dialysis membranes: specific adsorption of intact parathyroid hormone.
    Valat C; Pengloan J; Blanchier D; Bagros P; Besnard JC
    Nucl Med Commun; 1993 Feb; 14(2):130-6. PubMed ID: 8429992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
    Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
    Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactive parathyroid hormone and calcitonin in plasma and ultrafiltrate before and after haemodialysis.
    Fauchald P; Gautvik VT; Gautvik KM
    Scand J Clin Lab Invest; 1985 May; 45(3):229-35. PubMed ID: 4001828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hemodialysis membrane type on parathyroid hormone removal.
    Kudlac H; Fielding AM; Williams AJ
    Miner Electrolyte Metab; 1994; 20(5):245-9. PubMed ID: 7700210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adsorption of oxacalcitriol by polysulphone haemodialyser in patients with secondary hyperparathyroidism.
    Tsuruoka S; Yamamoto H; Ioka T; Ando H; Saito T; Fujimura A
    Br J Clin Pharmacol; 2004 Nov; 58(5):488-95. PubMed ID: 15521896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iPTH values during hemodialysis: role of ionized Ca, dialysis membranes and iPTH assays.
    D'Amour P; Jobin J; Hamel L; L'Ecuyer N
    Kidney Int; 1990 Aug; 38(2):308-14. PubMed ID: 2402123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis membranes and PTH changes during hemodialysis in patients with secondary hyperparathyroidism.
    De Francisco AL; Amado JA; Prieto M; Alcalde G; Sanz de Castro S; Ruiz JC; Morales P; Arias M
    Nephron; 1994; 66(4):442-6. PubMed ID: 8015649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
    Bellazzi R; Romanini D; Bacchella L; Nai M; Aprile C; Santagostino M; De Vincenzi A
    Nephron; 1991; 57(3):273-82. PubMed ID: 2017266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?
    Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J
    Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism.
    Kazama JJ; Omori K; Higuchi N; Takahashi N; Ito Y; Maruyama H; Narita I; Cantor TL; Gao P; Gejyo F
    Nephrol Dial Transplant; 2004 Apr; 19(4):892-7. PubMed ID: 15031346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bio-intact parathyroid hormone and intact parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism receiving intravenous calcitriol therapy.
    Fujimori A; Sakai M; Yoshiya K; Shin J; Kim JI; Inaba Y; Miyamoto T; Inoue S; Fukagawa M
    Ther Apher Dial; 2004 Dec; 8(6):474-9. PubMed ID: 15663547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
    Kokuho T; Toya Y; Kawaguchi Y; Tamura K; Iwatsubo K; Dobashi Y; Nakazawa A; Takeda H; Iwatsubo M; Hirawa N; Yasuda G; Ohnishi T; Umemura S
    Ther Apher Dial; 2007 Dec; 11(6):442-8. PubMed ID: 18028171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy.
    Murakami R; Murakami S; Tsushima R; Ueda C; Mikami K; Ebina T; Kumasaka R; Nakamura N; Okumura K
    Nephrol Dial Transplant; 2008 Jan; 23(1):315-20. PubMed ID: 17956892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of haemodialysis on markers of bone turnover in children.
    Waller S; Ridout D; Rees L
    Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
    Lee SA; Lee MJ; Ryu GW; Jhee JH; Kim HW; Park S; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
    Osteoporos Int; 2016 Sep; 27(9):2717-2726. PubMed ID: 27216997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can calcium, phosphate, calcium phosphate product and intact parathyroid hormone levels be appropriately controlled in dialysis patients?
    Deger SM; Mutluay R; Derici U; Mandiralioglu F; Arinsoy T; Sindel S
    Med Princ Pract; 2011; 20(1):85-9. PubMed ID: 21160221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fate of parathyroid hormone during hemodialysis and ultrafiltration.
    Burckhardt P; Jaeger P; Jacquet AF; Wauters JP
    Horm Res; 1985; 21(1):46-54. PubMed ID: 3972336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there any differences in the parathyroid response in the different types of renal osteodystrophy?
    Olaizola I; Aznarez A; Jorgetti V; Petraglia A; Caorsi H; Acuña G; Fajardo L; Ambrosoni P; Mazzuchi N
    Nephrol Dial Transplant; 1998; 13 Suppl 3():15-8. PubMed ID: 9580536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Ca2+ concentration on the clearance and circulating levels of intact and carboxy-terminal iPTH in pentobarbital-anesthetized dogs.
    D'Amour P; Rousseau L; Rocheleau B; Pomier-Layrargues G; Huet PM
    J Bone Miner Res; 1996 Aug; 11(8):1075-85. PubMed ID: 8854243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.